Consistent with that observed in other brain diseases, we suggest that the dopaminergic degeneration and the accompanying neuroinflammation produce, by the above-mentioned mechanisms, an increase in modified AT1 receptors (neoantigens), which after neuron degeneration, reach the CSF, and, via the brain lymphatic system, the cervical lymph nodes. The gene discussed is AGTR1; the disease is brain disorder.